Essity (ESSITY) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
3 Feb, 2026New financial targets and ambitions
Set annual organic sales growth target above 3% and EBITA margin above 15%, raising previous ambitions after the Vinda divestment.
Share buyback program of SEK 3 billion to begin June 17, 2024, and run until AGM 2025, intended as a recurring capital allocation tool funded by strong operating cash flow.
Financial policies remain unchanged, focusing on maintaining a solid investment grade rating and stable, rising dividends.
Acquisitions remain strategic but are no longer included in the annual growth target.
Enhanced ambition reflects strong market positions, innovation, and efficiency improvements.
Strategic focus and market outlook
Emphasis on growth in high-margin, less capital-intensive categories, leveraging strong market positions and brands.
Focused on profitable growth in Health & Medical, Consumer Goods, and Professional Hygiene, with global leadership in 90% of sales.
Market trends are favorable, driven by higher living standards, aging populations, increased health awareness, and chronic conditions.
Exposed to global market growth rates of 2–4%, with Health & Medical and Asia showing higher growth potential.
Growth strategy includes increased A&P investment, innovation, and a focus on superior product offerings.
Margin improvement and operational efficiency
Margin improvement to be achieved through operating leverage, cost focus, premiumization, innovation, and organic portfolio changes, not further divestments.
Incentive programs have shifted to prioritize growth alongside margin protection, with changes already implemented for 2024.
Efficiency gains and a balanced product portfolio support the margin target, with over 36% of costs fixed, enabling scale benefits.
Portfolio optimized for efficiency, lower volatility, and increased pricing power, with strong financial position and attractive dividend/EPS growth.
Roadmap to EBITA margin target includes product mix improvement, innovation, efficiency gains, and operating leverage.
Latest events from Essity
- Aiming for 3%+ organic growth and 15%+ margins, driven by innovation, brands, and efficiency.ESSITY
CMD 202417 Mar 2026 - Profitable growth is fueled by innovation, acquisitions, and strong global brand leadership.ESSITY
UBS Global Consumer and Retail Conference13 Mar 2026 - Record EBITA and margin gains, new growth targets, and a SEK 3bn buyback boost value.ESSITY
Q2 20243 Feb 2026 - Portfolio shift and strong margins drive growth and future flexibility.ESSITY
21st Annual dbAccess Global Consumer Conference 202431 Jan 2026 - Profitability and margins rose in Q4 2025, supported by acquisitions and cost-saving actions.ESSITY
Q4 202522 Jan 2026 - Record cash flow, margin gains, and reduced net debt mark a robust Q3 2024.ESSITY
Q3 202418 Jan 2026 - Record sales, profit, and higher dividend in 2024, with focus on growth and innovation for 2025.ESSITY
Q4 202410 Jan 2026 - Q1 2025 saw sales growth, strong cash flow, and a new SEK 3bn share buyback program.ESSITY
Q1 202521 Dec 2025 - Record profits, innovation, and high-margin growth drive strong 2024 results and future targets.ESSITY
UBS Global Consumer and Retail Conference 202520 Dec 2025